{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:46:25Z","timestamp":1755225985176,"version":"3.43.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,13]]},"DOI":"10.7759\/cureus.90020","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:53:29Z","timestamp":1755122009000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperferritinemia as a Clue to Neuroendocrine Carcinoma"],"prefix":"10.7759","author":[{"given":"Eugene S","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charity","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/mtomcs\/mfab021","article-title":"Chemistry and biology of ferritin","volume":"13","author":"Plays M","year":"2021","unstructured":"Plays M, M\u00fcller S, Rodriguez R. Chemistry and biology of ferritin. Metallomics. 2021, 13:10.1093\/mtomcs\/mfab021","journal-title":"Metallomics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"Knovich MA","year":"2009","unstructured":"Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009, 23:95-104. 10.1016\/j.blre.2008.08.001","journal-title":"Blood Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1978.tb00374.x","article-title":"Serum ferritin during infection. A longitudinal study","volume":"21","author":"Birgeg\u00e5rd G","year":"1978","unstructured":"Birgeg\u00e5rd G, H\u00e4llgren R, Killander A, Str\u00f6mberg A, Venge P, Wide L. Serum ferritin during infection. A longitudinal study. Scand J Haematol. 1978, 21:333-40. 10.1111\/j.1600-0609.1978.tb00374.x","journal-title":"Scand J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102778","article-title":"Ferritin - from iron, through inflammation and autoimmunity, to COVID-19","volume":"126","author":"Mahroum N","year":"2022","unstructured":"Mahroum N, Alghory A, Kiyak Z, Alwani A, Seida R, Alrais M, Shoenfeld Y. Ferritin - from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun. 2022, 126:102778. 10.1016\/j.jaut.2021.102778","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/76.4.605","article-title":"Iron-binding proteins and risk of cancer in Taiwan","volume":"76","author":"Stevens RG","year":"1986","unstructured":"Stevens RG, Beasley RP, Blumberg BS. Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst. 1986, 76:605-10. 10.1093\/jnci\/76.4.605","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47010060","article-title":"Ferritin as an effective prognostic factor and potential cancer biomarker","volume":"47","author":"Szymulewska-Konopko K","year":"2025","unstructured":"Szymulewska-Konopko K, Resze\u0107-Gie\u0142a\u017cyn J, Ma\u0142eczek M. Ferritin as an effective prognostic factor and potential cancer biomarker. Curr Issues Mol Biol. 2025, 47:10.3390\/cimb47010060","journal-title":"Curr Issues Mol Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky B","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017, 19:991-1002. 10.1016\/j.neo.2017.09.002","journal-title":"Neoplasia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.20984","article-title":"Hindered submicron mobility and long-term storage of presynaptic dense-core granules revealed by single-particle tracking","volume":"72","author":"Scalettar BA","year":"2012","unstructured":"Scalettar BA, Jacobs C, Fulwiler A, Prahl L, Simon A, Hilken L, Lochner JE. Hindered submicron mobility and long-term storage of presynaptic dense-core granules revealed by single-particle tracking. Dev Neurobiol. 2012, 72:1181-95. 10.1002\/dneu.20984","journal-title":"Dev Neurobiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0014","article-title":"The diagnosis and medical management of advanced neuroendocrine tumors","volume":"25","author":"Kaltsas GA","year":"2004","unstructured":"Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004, 25:458-511. 10.1210\/er.2003-0014","journal-title":"Endocr Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss G","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019, 133:40-50. 10.1182\/blood-2018-06-856500","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon BR","year":"2011","unstructured":"Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011, 54:328-43. 10.1002\/hep.24330","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi G","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, et al.. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022, 33:115-54. 10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.12.002","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?","volume":"96","author":"Bellizzi AM","year":"2020","unstructured":"Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?. Hum Pathol. 2020, 96:8-33. 10.1016\/j.humpath.2019.12.002","journal-title":"Hum Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31829ce01f","article-title":"Causes and significance of markedly elevated serum ferritin levels in an academic medical center","volume":"19","author":"Moore C Jr","year":"2013","unstructured":"Moore C Jr, Ormseth M, Fuchs H. Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol. 2013, 19:324-8. 10.1097\/RHU.0b013e31829ce01f","journal-title":"J Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-24-0757","article-title":"Strength in numbers: identifying a significant association between high serum ferritin levels and newly diagnosed malignancy in a large health organization cohort","volume":"34","author":"Gesher AS","year":"2025","unstructured":"Gesher AS, Grinin K, Atias D, Patalon T, Gazit S, Hoshen M, Dagan A. Strength in numbers: identifying a significant association between high serum ferritin levels and newly diagnosed malignancy in a large health organization cohort. Cancer Epidemiol Biomarkers Prev. 2025, 34:190-6. 10.1158\/1055-9965.EPI-24-0757","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.640.640","article-title":"Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome","volume":"112","author":"Sanz G","year":"2008","unstructured":"Sanz G, Nomdedeu B, Such E, et al.. Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome. Blood. 2008, 112:640. 10.1182\/blood.V112.11.640.640","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.03.009","article-title":"Clinical significance of serum ferritin at diagnosis in patients with acute myeloid leukemia: a YACHT multicenter retrospective study","volume":"18","author":"Tachibana T","year":"2018","unstructured":"Tachibana T, Andou T, Tanaka M, et al.. Clinical significance of serum ferritin at diagnosis in patients with acute myeloid leukemia: a YACHT multicenter retrospective study. Clin Lymphoma Myeloma Leuk. 2018, 18:415-21. 10.1016\/j.clml.2018.03.009","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020367","article-title":"Iron overload in children with acute lymphoblastic and acute myeloblastic leukemia-experience of one center","volume":"16","author":"Sawicka-Zukowska M","year":"2024","unstructured":"Sawicka-Zukowska M, Kretowska-Grunwald A, Kania A, et al.. Iron overload in children with acute lymphoblastic and acute myeloblastic leukemia-experience of one center. Cancers (Basel). 2024, 16:367. 10.3390\/cancers16020367","journal-title":"Cancers (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.47176\/mjiri.35.162","article-title":"Serum ferritin, vitamin D and pathological factors in breast cancer patients","volume":"35","author":"Fadavi P","year":"2021","unstructured":"Fadavi P, Nafisi N, Hariri R, et al.. Serum ferritin, vitamin D and pathological factors in breast cancer patients. Med J Islam Repub Iran. 2021, 35:162. 10.47176\/mjiri.35.162","journal-title":"Med J Islam Repub Iran"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i33.12230","article-title":"Prognostic role of pretreatment serum ferritin concentration in lung cancer patients: a meta-analysis","volume":"10","author":"Gao Y","year":"2022","unstructured":"Gao Y, Ge JT. Prognostic role of pretreatment serum ferritin concentration in lung cancer patients: a meta-analysis. World J Clin Cases. 2022, 10:12230-9. 10.12998\/wjcc.v10.i33.12230","journal-title":"World J Clin Cases"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/172460080602100407","article-title":"Serum ferritin in colorectal cancer patients and its prognostic evaluation","volume":"21","author":"Lorenzi M","year":"2006","unstructured":"Lorenzi M, Lorenzi B, Vernillo R. Serum ferritin in colorectal cancer patients and its prognostic evaluation. Int J Biol Markers. 2006, 21:235-41. 10.1177\/172460080602100407","journal-title":"Int J Biol Markers"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202111_27091","article-title":"Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer","volume":"25","author":"Demir H","year":"2021","unstructured":"Demir H, Beypinar I, Urvay S, Davarc\u0131 SE, Baykara M. Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer. Eur Rev Med Pharmacol Sci. 2021, 25:6473-9. 10.26355\/eurrev_202111_27091","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-021-00738-3","article-title":"Prognostic value of international normalized ratio-to-albumin ratio and ferritin level in chronic liver patients with hepatocellular carcinoma","volume":"53","author":"\u00dclger Y","year":"2022","unstructured":"\u00dclger Y, Delik A. Prognostic value of international normalized ratio-to-albumin ratio and ferritin level in chronic liver patients with hepatocellular carcinoma. J Gastrointest Cancer. 2022, 53:1028-33. 10.1007\/s12029-021-00738-3","journal-title":"J Gastrointest Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-013-0367-5","article-title":"Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study","volume":"33","author":"Patil PS","year":"2014","unstructured":"Patil PS, Mohandas KM, Bhatia SJ, Mehta SA. Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study. Indian J Gastroenterol. 2014, 33:12-8. 10.1007\/s12664-013-0367-5","journal-title":"Indian J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02575-x","article-title":"The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma","volume":"23","author":"Liu J","year":"2023","unstructured":"Liu J, Xuan B, Quan Q, Gong S, Mu X. The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma. BMC Womens Health. 2023, 23:415. 10.1186\/s12905-023-02575-x","journal-title":"BMC Womens Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144687","article-title":"Role of selected circulating tumor biomarkers in patients with skeletal metastatic pancreatic neuroendocrine neoplasms","volume":"12","author":"Rosiek V","year":"2023","unstructured":"Rosiek V, Janas K, Witkowska M, Kos-Kud\u0142a B. Role of selected circulating tumor biomarkers in patients with skeletal metastatic pancreatic neuroendocrine neoplasms. J Clin Med. 2023, 12:4687. 10.3390\/jcm12144687","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100533","article-title":"Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms","volume":"31","author":"Rosiek V","year":"2022","unstructured":"Rosiek V, W\u00f3jcik-Giertuga M, Kos-Kud\u0142a B. Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms. Cancer Treat Res Commun. 2022, 31:100533. 10.1016\/j.ctarc.2022.100533","journal-title":"Cancer Treat Res Commun"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00090","article-title":"Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure","volume":"5","author":"Hu CD","year":"2015","unstructured":"Hu CD, Choo R, Huang J. Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure. Front Oncol. 2015, 5:90. 10.3389\/fonc.2015.00090","journal-title":"Front Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000109711","article-title":"Neuroendocrine differentiation in prostate cancer: from lab to bedside","volume":"79","author":"Cindolo L","year":"2007","unstructured":"Cindolo L, Cantile M, Vacherot F, Terry S, de la Taille A. Neuroendocrine differentiation in prostate cancer: from lab to bedside. Urol Int. 2007, 79:287-96. 10.1159\/000109711","journal-title":"Urol Int"},{"key":"ref31","article-title":"The neuroendocrine phenotype in prostate cancer: basic and clinical aspects","volume":"28","author":"Mosca A","year":"2005","unstructured":"Mosca A, Berruti A, Russo L, Torta M, Dogliotti L. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. J Endocrinol Invest. 2005, 28:141-5.","journal-title":"J Endocrinol Invest"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.12.064","article-title":"Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapy","volume":"81","author":"Krauss DJ","year":"2011","unstructured":"Krauss DJ, Hayek S, Amin M, et al.. Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 2011, 81:e119-25. 10.1016\/j.ijrobp.2010.12.064","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14977","article-title":"Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer","volume":"8","author":"Wang X","year":"2017","unstructured":"Wang X, An P, Zeng J, et al.. Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer. Oncotarget. 2017, 8:17862-72. 10.18632\/oncotarget.14977","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382293-hyperferritinemia-as-a-clue-to-neuroendocrine-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:53:30Z","timestamp":1755122010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382293-hyperferritinemia-as-a-clue-to-neuroendocrine-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.90020","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}